Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Esilida Sula Karreci, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sula Karreci, Esilida; Kruger Gomes, Larissa; Schulman, Ruth; Agarwal, Krishna A; Pandit, Amar; Denker Bradley M. An Unusual Cause of Rhabdomyolysis. 2020. View Publication.
  2. Kruger Gomes, Larissa; Sula Karreci, Esilida; Agarwal, Krishna A; Schulman, Ruth; William, Jeffrey H; Lecker, Stewart H; Stillman, Isaac Ely. Sabotaged: Hydralazine-Induced ANCA Glomerulonephritis. 2020; (1203). View Publication.
  3. Agarwal, Krishna A; Sula Karreci, Esilida; Kruger Gomes, Larissa; Stillman, Isaac Ely; Lecker, Stewart H; Steinman, Theodore; Denker Bradley M. C3 Glomerulonephritis: Diagnostic Challenges and Overlap Syndromes. 2020; (1202). View Publication.
  4. Schulman, Ruth; Kruger Gomes, Larissa; Agarwal, Krishna A; Sula Karreci, Esilida; Hoenig, Melanie P. Skim the Fat: PLEX for Hypertriglyceridemia-Induced CRRT Clotting. 2020; (701). View Publication.
  5. Agarwal, Krishna A; Kruger Gomes, Larissa; Sula Karreci, Esilida; Schulman, Ruth; Heher, Yael K; Denker Bradley M. Drug-Induced Thrombotic Microangiopathy from Trimethoprim-Sulfamethoxazole. 2020; (103). View Publication.
  6. H. Patel1, V. Nissaisorakarn2, E. Sula Karrecci1, N. Agrawal1, F. Cardarelli1. Comparative analysis of risk factors and outcomes in kidney transplant recipients with lung cancer and those with no malignancy. 2020; (B-208). View Publication.
  7. Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018 06 01; 128(6):2487-2499. PMID: 29558366; PMCID: PMC5983341.
    Citations: 35     Fields:    Translation:AnimalsCells
  8. Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J. Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. JCI Insight. 2017 11 02; 2(21). PMID: 29093262.
    Citations: 15     Fields:    Translation:HumansCells
  9. S. Routray, E. Karreci, M. Uehara, J. Assaker, A. Mihali, S. Eskandari, L. Riella, R. Abdi, Y. Kawano, C. Nathan, G. Lin, J. Azzi. Designing a Novel Selective Immunoproteasome Inhibitor Reveals a Critical Role of the IP and STAT5 Pathway in Regulating T Cell Exhaustion and Promoting Long Term Heart Allograft Acceptance. 2017; (211). View Publication.
  10. Sula Karreci E, Fan H, Uehara M, Mihali AB, Singh PK, Kurdi AT, Solhjou Z, Riella LV, Ghobrial I, Laragione T, Routray S, Assaker JP, Wang R, Sukenick G, Shi L, Barrat FJ, Nathan CF, Lin G, Azzi J. Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice. Proc Natl Acad Sci U S A. 2016 12 27; 113(52):E8425-E8432. PMID: 27956634; PMCID: PMC5206568.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  11. A. Mihali,1 E. Sula Karreci,1 A. Kurdi,3 L. Riella,1 Y. Kawano,3 H. Fan,2 P. Singh,2 I. Ghobrial,3 C. Nathan,2 G. Lin,2 J. Azzi.1. Designing and Synthesizing a Novel Highly Selective Immunoproteasome Inhibitor That Promotes Long Term Heart Allograft Acceptance While Reducing Plasma Cells and Donor Specific Antibodies. 2016; (469). View Publication.
  12. E. Sula Karreci,1 A. Mihali,1 M. Uehara,1 A. Kurdi,1 L. Riella,1 R. Abdi,1 H. Fan,2 P. Singh,2 C. Nathan,2 G. Lin,2 J. Azzi.1. Designing a Novel Highly Selective Immunoproteasome Inhibitor That Promotes Longterm Heart Allograft Acceptance While Inducing Immune Cell Exhaustion, Treg Induction and Memory Cell Suppression. 2016; (84). View Publication.
  13. Yawara Kawano, MD, PhD1*, Michele Moschetta, MD1*, Katsutoshi Kokubun, PhD1*, Pavlo Lukyanchykov, MD2*, Esilida Sula Karreci, MD2*, Salomon Manier, MD1, Shokichi Tsukamoto, MD, PhD1, Satoshi Takagi, PhD1, Jiantao Shi3*, Michaela R. Reagan, PhD4, Daisy Huynh, BS, MS1*, Antonio Sacco, BS1*, David M. Dorfman, MD, PhD5, Marta Chesi, PhD6, Peter Leif Bergsagel, MD, PhD7, Aldo M Roccaro, MD, PhD1, Jamil Azzi, MD2* and Irene M. Ghobrial, MD8. 502 Characterization of the Role of Regulatory T Cells (Tregs) in Inducing Progression of Multiple Myeloma. 2015. View Publication.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sula Karreci's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (35)
Co-Authors (14)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.